- Home
- GNSS vs XTNT Comparison
GNSS vs XTNT Comparison
Compare GNSS & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNSS
- XTNT
- Stock Information
- Founded
- GNSS 1992
- XTNT N/A
- Country
- GNSS United States
- XTNT United States
- Employees
- GNSS N/A
- XTNT N/A
- Industry
- GNSS Consumer Electronics/Appliances
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GNSS Consumer Staples
- XTNT Health Care
- Exchange
- GNSS Nasdaq
- XTNT Nasdaq
- Market Cap
- GNSS 108.4M
- XTNT 110.6M
- IPO Year
- GNSS N/A
- XTNT N/A
- Fundamental
- Price
- GNSS $2.24
- XTNT $0.69
- Analyst Decision
- GNSS Strong Buy
- XTNT Strong Buy
- Analyst Count
- GNSS 1
- XTNT 1
- Target Price
- GNSS $5.75
- XTNT $1.50
- AVG Volume (30 Days)
- GNSS 107.4K
- XTNT 396.1K
- Earning Date
- GNSS 12-08-2025
- XTNT 11-10-2025
- Dividend Yield
- GNSS N/A
- XTNT N/A
- EPS Growth
- GNSS N/A
- XTNT N/A
- EPS
- GNSS N/A
- XTNT 0.01
- Revenue
- GNSS $30,470,000.00
- XTNT $133,083,000.00
- Revenue This Year
- GNSS $85.24
- XTNT $13.03
- Revenue Next Year
- GNSS $78.33
- XTNT N/A
- P/E Ratio
- GNSS N/A
- XTNT $61.68
- Revenue Growth
- GNSS 8.95
- XTNT 16.88
- 52 Week Low
- GNSS $1.46
- XTNT $0.33
- 52 Week High
- GNSS $4.04
- XTNT $0.95
- Technical
- Relative Strength Index (RSI)
- GNSS 47.20
- XTNT 41.31
- Support Level
- GNSS $2.20
- XTNT $0.64
- Resistance Level
- GNSS $2.45
- XTNT $0.83
- Average True Range (ATR)
- GNSS 0.11
- XTNT 0.07
- MACD
- GNSS -0.01
- XTNT -0.02
- Stochastic Oscillator
- GNSS 40.23
- XTNT 13.84
About GNSS Genasys Inc.
Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.